Ex vivo storage of human osteochondral allografts: Long‐term analysis over 300 days using a Ringer‐based solution
Journal of Orthopaedic Research · 2024
DOI: 10.1002/jor.25821 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Orthopaedic Research, 2024. Verfasst von Zhida Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Trauma Surgery, Hannover Medical School, Hannover, Germany. Hauptthemen laut MEDLINE: Allografts, Ringer's Solution, Glycosaminoglycans, Chondrocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Large osteochondral defects are a major challenge in orthopedics, for which osteochondral allograft (OCA) transplantation is nowadays considered as an option, especially in young patients. However, a major issue with OCA is the need for graft storage, which ensures adequate cartilage integrity over time. The aim of this study was to test how long a Ringer‐based storage solution can provide good graft quality after explantation and thus meet the requirements for OCA. For this purpose, human osteochondral allografts of the knee and ankle were analyzed. Live/Dead analysis was performed and glycosaminoglycan, as well as hydroxyproline content, were measured as crucial chondrocyte integrity factors. Furthermore, biomechanical tests focusing on stress relaxation and elastic compression modulus were performed. The critical value of 70% living chondrocytes, which corresponds to a number of 300 cells/mm², was reached after an average of 16 weeks of storage. In addition, a constant cell shrinkage was observed over time. The amount of glycosaminoglycan and hydroxyroline showed a slight and constant decrease over time, but no significant differences when compared from Day 0 to the values at Weeks 40–43. Biomechanical testing also revealed no significant differences at the different time points. Therefore, the results show that the Ringer‐based storage solution at 4°C is able to provide a chondrocyte survival of 70% until Week 16. This is comparable to previously published storage solutions. Therefore, the study contributes to the establishment of a Ringer‐based osteochondral allograft transplantation system for countries where medium‐based storage solution cannot be approved.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Trauma Surgery, Hannover Medical School, Hannover, Germany.
- Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Center for Musculoskeletal Surgery, Berlin, Germany.
- Berlin Institute of Health at Charité, Universitätsmedizin Berlin, Julius Wolff Institute, Berlin, Germany.
- Berlin Institute of Health at Charité, Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Berlin, Germany.
ORCID-Profile: Christian Krettek, Claudia Neunaber
Zitieren
APA
Jiang, Z., Clausen, J. D., Jahn, D., Wulsten, D., Gladitz, L. M., Bundkirchen, K., Krettek, C., & Neunaber, C. (2024). Ex vivo storage of human osteochondral allografts: Long‐term analysis over 300 days using a Ringer‐based solution. Journal of Orthopaedic Research. https://doi.org/10.1002/jor.25821
Vancouver
Jiang Z, Clausen JD, Jahn D, Wulsten D, Gladitz LM, Bundkirchen K, et al. Ex vivo storage of human osteochondral allografts: Long‐term analysis over 300 days using a Ringer‐based solution. Journal of Orthopaedic Research. 2024. doi:10.1002/jor.25821
BibTeX
@article{Jiang2024,
author = {Jiang, Zhida and Clausen, Jan-Dierk and Jahn, Denise and Wulsten, Dag and Gladitz, Luisa M and Bundkirchen, Katrin and Krettek, Christian and Neunaber, Claudia},
title = {Ex vivo storage of human osteochondral allografts: Long‐term analysis over 300 days using a Ringer‐based solution},
journal = {Journal of Orthopaedic Research},
year = {2024},
doi = {10.1002/jor.25821}
}
EUVIMED